Page 145 - Annual report 2021-22
P. 145
Annual Report 2021-22 |
MLP2013 MOLECULAR MECHANISMS OF HOW NON-CODING RNAS IMPACT EPIGENETIC REGULATION
STUDY OF THE POTENTIAL ROLE OF PARENTALLY INHERITED NON-CODING RNA AS CELL DIVISION
MLP2102
COUNTERS DURING EARLY EMBRYONIC DEVELOPMENT IN ZEBRAFISH
IMPACT OF SOCIAL ISOLATION ON COGNITIVE PERFORMANCE AND THE ROLE OF HISTONE ACETYL
MLP2107
TRANSFERASES
128
INVESTIGATING THE ROLE OF BLM HELICASE AS A GLOBAL TUMOR SUPPRESSOR: UNDERSTANDING ITS
GAP0116 REGULATORY LOOPS AND USING THE KNOWLEDGE FOR THERAPEUTIC AND CLINICAL APPLICATIONS IN
CANCER BIOLOGY
TARGETING TELOMERASE TRANSCRIPTIONALLY AND POST-TRANSCRIPTIONALLY USING SMALL
GAP0143 MOLECULES AND ANTI-TELOMERASE PEPTIDES: POTENTIAL DOUBLE BLOW TO AGGRESSIVE DRUG
RESISTANT CANCERS
UNDERSTANDING DIFFERENCES IN THE PATTERNS OF OSTEOARTHRITIS IN INDIAN AND WESTERN
GAP0152
POPULATION: IMPACT ON SYMPTOMS, TREATMENT OPTIONS AND THEIR OUTCOME
DELINEATING AND MODULATING THE FUNCTION OF Ep300 IN THE MOLECULAR PATHOLOGY OF
GAP0153
RUBINSTEIN TAYBI SYNDROME
DECIPHERING THE ROLE OF GUIDANCE CUES ON MELANOCYTE MIGRATION, PATTERNING AND
GAP0165
SURVIVAL: TOWARDS REGENERATIVE APPROACH FOR VITILIGO
POPULATION-BASED RESEARCH STUDIES TO UNDERSTAND DISEASE DYNAMICS TOWARDS EFFECTIVE
GAP0166 MANAGEMENT OF PREVENTION AND TREATMENT OF HIV/AIDS, INCLUDING CO-MORBIDITIES AND CO-
INFECTIONS-PHASE-II OF THE COLLABORATIVE PROGRAMME ON HIV/AIDS RESEARCH
GAP0171 GENOME EDITING APPLIED TO TELOMERASE REACTIVATION IN AGGRESSIVE CANCER PROGRESSION
IMPROVING DETECTABILITY OF DISORDERS USING CELL FREE DNA IN PLASMA WITH GENOME WIDE
GAP0181
SIGNAL PROCESSING
GENOME ENGINEERING TO GENERATE CELL AND ANIMAL MODELS TO DELINEATE MELANOCYTE CELL
GAP0182
FATE DECISIONS
NON-CODING RNA AS MEDIATORS OF LONG-TERM COGNITIVE EFFECTS FOLLOWING EARLY LIFE
GAP0197
PERTURBATIONS
MOLECULAR MECHANISMS OF HOW TELOMERES IMPACT GLOBAL GENE EXPRESSION:POTENTIAL ROLE
GAP0200
OF TRF2 IN TELOMERE-CHROMATIN INTERACTION
ROLE OF TELOMERE LENGTH AND TELEMORE-BINDING FACTOR (SHELTERIN) IN NEURONAL
GAP0202
DIFFERENTIATION AND ITS POTENTIAL IMPACT IN AN ALZHEIMER'S DISEASE MODEL
AN OBSERVATIONAL MECHANISTIC STUDY ON THE ROLES OF NCRNAS IN THE LIVER DURING DIABETES
GAP0203
: IMPLICATIONS IN FATTY LIVER &; GLUCONEOGENESIS
A COMBINED METABOLOME AND PROTEOME PROFILING TO DEVELOP A PREDICTIVE BIOMARKER SET
GAP0212
FOR RHEUMATOID ARTHRITIS ASSESSMENT
GAP0214 INVESTIGATING SARS-CoV2 3'-5' EXONUCLEASE (NSP14/ExoN) AS THERAPEUTIC TARGET FOR CoVID19
GAP0227 DELHI CLUSTER: DELHI RESEARCH IMPLEMENTATION AND INNOVATION (DRLLV)